TrialScientific reports2025

Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules.

Asada Leelahavanichkul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.